aluminum oxide has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcock, IM; Ardestani, MS; Athari, SS; Folkerts, G; Garssen, J; Moazzeni, SM; Moin, M; Mortaz, E; Movassaghi, M; Pourpak, Z | 1 |
1 other study(ies) available for aluminum oxide and vasoactive intestinal peptide
| Article | Year |
|---|---|
Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice.
Topics: Aluminum Oxide; Animals; Anti-Asthmatic Agents; Asthma; Drug Carriers; Drug Stability; Eosinophilia; Female; Immunoglobulin E; Lung; Mice; Nanoparticles; Vasoactive Intestinal Peptide | 2016 |